Symptomatica: A MedTech Startup for Investors
The medical AI market is experiencing one of the fastest growth periods in the history of technology. Billions of people around the world face the same problem every day: something hurts, something feels off — and they have no idea what to do about it. Symptomatica solves exactly that.
If you are looking for a promising medtech startup with a working product, real users, and a clear development plan — this page is for you.
The Market: Why Medical AI Is a Major Opportunity
The global AI in healthcare market was valued at approximately $20 billion in 2023 and is projected to exceed $180 billion by 2030. This is one of the few sectors where technology does not merely automate existing processes — it creates fundamentally new value: access to quality medical information for people who previously had none.
In Russia and the CIS countries, the situation is particularly acute. Public clinics are overloaded, specialist appointments take weeks, and private healthcare is out of reach for many. People search for answers online — and find either alarming articles or forums filled with contradictory advice. A quality, personalized answer to "what is happening to me" simply does not exist.
That is the market opportunity. Symptomatica occupies the space between "searching online" and "visiting a doctor" — a gap where nothing good currently exists.
The Problem Symptomatica Solves
Imagine: you have had a headache for several days. You go to Google, type in your symptoms — and receive dozens of articles, half of which suggest cancer and the other half advise you to "just rest." You do not know how serious this is, which doctor to see, or whether you need to go right now.
That is stress. That is wasted time. And it happens to millions of people every day.
Symptomatica replaces chaotic searching with structured dialogue. The user describes their symptoms, the AI asks clarifying questions, and delivers a concrete answer: how urgent the situation is, which specialist to see, what can be done right now. Not a list of twenty possible diagnoses — navigation.
Additionally: lab result interpretation, drug interaction checks, specialist matching by symptom. All in one place, no registration required for the first queries.
The Product: What Is Working Right Now
Symptomatica is not a concept or an MVP in development. It is a working product with real users.
The current entry point is a Telegram bot. Telegram was chosen deliberately: it is the most popular messaging platform in Russia and the CIS, requires no separate app installation, and works on any device. The user simply opens a chat and starts a conversation.
What is already available to users:
- Symptom analysis through structured dialogue with urgency assessment.
- Interpretation of blood and urine test results with explanation of each marker.
- Drug interaction check — whether medications can be taken together.
- Specialist matching based on symptom description — which doctor to see.
- First 5 queries free, no registration, no credit card required.
Monetization model: pay-per-request. The user tops up their balance and pays only for specific queries. No subscriptions, no recurring charges.
Development Plans: Where We Are Headed
The Telegram bot is the first entry point, not the final product. The roadmap includes several key directions.
Mobile app (iOS and Android). A dedicated app enables more: conversation history, personal health profile, notifications, a richer interface. This is the next step after Telegram.
Desktop client. A web version and desktop application for Windows and Mac — for users who prefer working from a computer.
Specific doctor recommendations. Today Symptomatica says "you need a cardiologist." In the future — "here are three cardiologists near you, their ratings and reviews, and the next available appointment." A shift from navigation to a complete route.
Laboratory integration. Direct retrieval of lab results — no manual entry. The user gets their tests done, and the results automatically appear in Symptomatica with interpretation.
WhatsApp bot. Expanding to the WhatsApp audience — particularly relevant for international markets.
B2B API for clinics. Integrating Symptomatica into healthcare organizations: pre-appointment history collection, automatic lab result interpretation for patients, reducing call center load.
Why Symptomatica Is the Right Bet
Medical AI is a competitive market. Why Symptomatica?
Focus. Symptomatica does not try to be "AI for everything." Only medicine, only patient navigation. This delivers depth that general-purpose solutions cannot match.
The right entry point. Telegram as the first platform is not a compromise — it is a strategy. Minimal barrier for users, fast feedback collection, product iteration without App Store update cycles.
No-subscription model. Pay-per-request lowers the entry barrier and increases conversion. The user makes no commitment — they simply try.
A clear path to B2B. Clinics, insurance companies, corporate wellness programs — a large market with high average contract value. Symptomatica is built with B2B integration in mind from day one.
A team that understands the product. Symptomatica was created by people who faced this problem themselves — and know how it should be solved.
Frequently Asked Questions
What market does Symptomatica operate in?
The primary market today is Russia and Russian-speaking users across the CIS. The service is available in Russian and English, which creates a foundation for international expansion. The long-term goal is the global medical AI market, valued in the hundreds of billions of dollars.
Are there already users?
Yes. Symptomatica is a working product with real users. The Telegram bot is active — people use the service to analyze symptoms, interpret lab results, and check medications. We collect feedback and iterate the product based on actual usage.
How is the service monetized?
The current model is pay-per-request. The first 5 queries are free; after that, the user tops up their balance and pays per query. This lowers the entry barrier and creates predictable revenue. Corporate pricing tiers and a B2B API with a different pricing model are planned.
What are the plans for the next year?
Priorities: mobile app for iOS and Android, expanded functionality (specific doctor recommendations, laboratory integration), user base growth, and first B2B partnerships with healthcare organizations. A detailed roadmap is available upon request.
How do I get in touch with the team?
If you are considering investing in medtech or want to discuss a partnership — reach out through the contact form on our site. We respond to all inquiries and are ready to provide detailed information about the product, metrics, and development plans.